Welcome to 2024 and the 201st edition of the CAC2 Childhood Cancer Community News Digest! Assorted News from the Last Week: The FDA granted a
For many, the holiday season is a time of joy, togetherness, and reflection. However, families dealing with the harsh reality of pediatric cancers face exceptional
Assorted News from the Last Week: CAC2 Members Nicole Scobie (Zoe4Life) and Nick Bird (Solving Kids’ Cancer-UK) contributed to this Journal of Clinical Oncology commentary
Assorted News from the Last Week: Dr. Andy Kolb of CAC2 Member Leukemia & Lymphoma Society explains why a well-meaning FDA policy is a threat
Assorted News from the Last Week: World Health Organization (WHO) Foundation report on global childhood cancer A collaboration of researchers has published successful results from
Assorted News from the Last Week: The Childhood Cancer Data Initiative (CCDI) awarded eight administrative supplements to NCI-Designated Cancer Centers to investigate how data in
Assorted News from the Last Week: World Health Organization joins forces with St. Jude Children’s Research Hospital and other key countries to coordinate vital humanitarian
Assorted News from the Last Week: While new treatments for leukemia have improved outcomes for many patients, children with Down syndrome have not benefited as
Assorted News from the Last Week: The US National Childhood Cancer Registry (NCCR) is combining data from myriad sources to hasten and improve research into
Assorted News from the Last Week: Trial results confirm effectiveness of Atezolizumab against a rare sarcoma. By a 14-6 vote, the Oncologic Drugs Advisory Committee
